Filing Details
- Accession Number:
- 0000950170-24-069553
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-05 20:01:54
- Reporting Period:
- 2024-06-03
- Accepted Time:
- 2024-06-05 20:01:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1812364 | Relay Therapeutics Inc. | RLAY | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1959229 | Peter Rahmer | C/O Relay Therapeutics, Inc. 399 Binney Street, 2Nd Floor Cambridge MA 02139 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-06-03 | 19,864 | $6.47 | 493,470 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-04 | 40,595 | $6.64 | 452,875 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-05 | 20,450 | $7.06 | 432,425 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 80,909 shares of restricted stock units ("RSUs") on May 31, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- Includes 384,434 shares underlying RSUs.
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2024.
- This transaction was executed in multiple trades at prices ranging from $6.56 to $6.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- This transaction was executed in multiple trades at prices ranging from $6.97 to $7.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
